Related Experiment Video

Updated: Feb 15, 2026

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases
06:56

Author Spotlight: Developing Tools to Tune the Activity of Tyrosine Phosphatases

Published on: September 6, 2024

829

Protein tyrosine phosphatases in cardiac physiology and pathophysiology

Fallou Wade1, Karim Belhaj2, Coralie Poizat3,4

  • 1Cardiovascular Research Program, King Faisal Specialist Hospital and Research Centre, PO Box 3354, Riyadh, 11211, Saudi Arabia.

Heart Failure Reviews
|February 4, 2018
PubMed

Insights

Protein tyrosine phosphatases (PTPs) are crucial regulators of heart function and development. Targeting PTPs offers a promising therapeutic strategy for heart failure by restoring signaling pathways.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Biochemistry

Background:

  • The heart's sensitivity to gene expression deregulation can lead to heart failure.
  • Protein phosphatases (PPs) regulate cardiac physiology and development, similar to protein kinases.
  • The PP family includes protein serine/threonine phosphatases and protein tyrosine phosphatases (PTPs).

Purpose of the Study:

  • To provide an overview of the role of PTPs in cardiac development and pathophysiology.
  • To highlight PTPs as potential therapeutic targets for heart failure.
  • To explore the restoration of PTP signaling in early and late stages of heart failure.

Main Methods:

  • Review of recent in silico studies.
  • Analysis of PTP subfamily roles in cardiac function.
  • Investigation of PTP signaling in heart failure.

Main Results:

  • PTPs play a significant role in heart development.
  • PTP dysregulation is implicated in cardiac pathophysiology.
  • In silico data supports PTPs as therapeutic targets.

Conclusions:

  • PTPs are vital for normal cardiac function and development.
  • Targeting PTPs may offer novel therapeutic avenues for heart failure.
  • Restoring PTP signaling is a key strategy for treating heart failure.
Keywords:
Cardiac hypertrophyHeart failurePTPProtein tyrosine phosphataseSmall-molecule inhibitor

More Related Videos

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology08:28

Experimental Models for Study of Retinal Pigment Epithelial Physiology and Pathophysiology

Published on: November 6, 2010

19.8K
Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

18.7K

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

4.5K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
1.7K
Physiology of the Heart: The Cardiac Cycle01:18

Physiology of the Heart: The Cardiac Cycle

The cardiac cycle describes the events from one heartbeat to the next. It includes three main phases: diastole, atrial systole, and ventricular systole, all driven by changes in chamber pressures and the function of heart valves.
Diastole: The Relaxation Phase
During diastole, all four heart chambers relax. The atrioventricular (AV) valves open, and the semilunar valves close. This phase sees the lowest chamber pressures, promoting ventricular filling. Venous blood enters the heart through the...
10.2K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
19.4K
Physiological Pharmacokinetic Models: Assumption with Protein Binding01:13

Physiological Pharmacokinetic Models: Assumption with Protein Binding

Physiological models with protein binding in pharmacokinetics offer a sophisticated approach to understanding drug disposition. These models consider drug-protein interactions, enabling them to effectively predict drug concentrations in different organs and tissues. This precision aids in accurate drug dosing, providing a significant advantage over conventional models. A key process within these models is equilibration, which ensures that drug concentrations achieve a steady state within the...
265